Kowalski Christine R 4
4 · Intersect ENT, Inc. · Filed Feb 3, 2021
Insider Transaction Report
Form 4
Kowalski Christine R
Chief Operations Officer
Transactions
- Award
Stock Options (Right to buy)
2021-02-01+29,750→ 29,750 totalExercise: $23.07Exp: 2031-02-01→ Common Stock (29,750 underlying) - Award
Common Stock
2021-02-01+15,234→ 42,269 total
Footnotes (3)
- [F1]Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the grant date.
- [F2]Includes 34,674 restricted stock units, of which 9,720 are performance based.
- [F3]The vesting commencement date of the option is February 1, 2021. 1/8th of the shares subject to the option shall vest on August 1, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.